🇵🇱Europe

Medical Device Regulation in Poland

Poland, as an EU member state, applies the EU Medical Device Regulation (EU MDR 2017/745) for the regulation of medical devices. The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPLWMiPB) serves as the national competent authority. Poland is one of the largest medical device markets in Central and Eastern Europe.

FrameworkEU Medical Device Regulation (EU MDR 2017/745); EU In Vitro Diagnostic Regulation (EU IVDR 2017/746); Polish Act on Medical Devices of 7 April 2022 (Ustawa o wyrobach medycznych).
Classification systemClass I / Class IIa / Class IIb / Class III
Primary agencyURPLWMiPB
RegionEurope
References tracked2
Updates this year3

Sources Tracked by Qalico

Qalico continuously monitors 2 references across guidelines, regulations, and standards for Poland.

Guidelines

URPL2 refs

Device Classification

Class IClass IIaClass IIbClass III

Poland follows the EU MDR classification system based on Annex VIII rules. Class I devices are low risk (e.g., stethoscopes, hospital beds). Class IIa devices are low-medium risk (e.g., dental crowns, hearing aids). Class IIb devices are medium-high risk (e.g., lung ventilators, bone fixation plates). Class III devices are the highest risk (e.g., coronary stents, breast implants).

Official classification guidance →

Standards & Key Principles

Applicable Standards

ISO 13485 – Quality Management Systems for Medical DevicesISO 14971 – Risk Management for Medical DevicesIEC 60601 – Safety and Performance of Medical Electrical EquipmentIEC 62304 – Medical Device Software Lifecycle ProcessesISO 10993 – Biological Evaluation of Medical DevicesPN (Polish National Standards) harmonized with EN standards

Key Principles

  • CE marking under EU MDR 2017/745 is mandatory for all devices on the Polish market.
  • Economic operators must register in the Polish national device database maintained by URPLWMiPB.
  • Polish language labeling and instructions for use are required.
  • The 2022 Polish Act on Medical Devices provides national implementing provisions for the EU MDR.
  • Clinical investigations require authorization from URPLWMiPB and a bioethics committee.

Pre-Market Requirements

Conformity Assessment

Manufacturers must complete conformity assessment procedures as specified in the EU MDR. Notified Body involvement is required for Class IIa, IIb, and III devices.

CE Marking

CE marking is required before placing any medical device on the Polish market.

National Registration

Manufacturers, authorized representatives, and importers must register with URPLWMiPB and notify the authority of devices placed on the Polish market.

Technical Documentation

Complete technical documentation in line with EU MDR Annexes II and III must be prepared and maintained, available for review by authorities.

Post-Market Requirements

Post-Market Surveillance (PMS)

A proactive PMS system must be maintained by manufacturers, proportionate to the risk class of the device.

Vigilance Reporting

Serious incidents and field safety corrective actions must be reported to URPLWMiPB per EU MDR vigilance requirements.

Periodic Safety Update Reports (PSUR)

PSURs must be submitted for Class IIa, IIb, and III devices, providing a systematic review of PMS data.

Market Surveillance

URPLWMiPB conducts market surveillance activities including inspections and product testing to ensure ongoing compliance.

International Recognition & Reliance

European Union

As an EU member state, Poland fully applies the EU MDR and recognizes CE-marked devices from any EU-designated Notified Body.

Stay on top of regulatory changes in Poland

Qalico monitors publications from URPLWMiPB in real time, surfacing updates that matter to your device category — so your team never misses a critical change.